Efficacy of the Potentized Homeopathic Drug, Carcinosin 200, Fed Alone and in Combination with Another Drug, Chelidonium 200, in Amelioration of p-Dimethylaminoazobenzene–Induced Hepatocarcinogenesis in Mice
- 1 October 2005
- journal article
- research article
- Published by SAGE Publications in The Journal of Alternative and Complementary Medicine
- Vol. 11 (5) , 839-854
Abstract
This study was conducted to examine whether the potentized homeopathic remedy Carcinosin 200, fed alone and in combination with Chelidonium 200, has differential protective effects against p-dimethylaminoazobenzene (p-DAB)-induced hepatocarcinogenesis in mice. Liver tumors were induced in mice through chronic feeding of p-DAB (initiator) and phenobarbital (PB, promoter). The mice were divided into two subgroups: (1) one was fed potentized Alcohol 200 and served as controls; and (2) the other was fed Carcinosin 200 alone or in combination with Chelidonium 200 and divided into several sets. The relative efficacy of the two potentized remedies, alone or in combination, in combating hepatocarcinogenesis was assessed through several cytogenetical endpoints such as chromosome aberrations, induction of micronuclei, sperm head anomaly, and mitotic index at several intervals of fixation (days 7, 15, 30, 60, 90, and 120). Several toxicity biomarkers such as acid and alkaline phosphatases, glutamate oxaloacetate transaminase, glutamate pyruvate transaminase, and lipid peroxidation activity were also assayed in three organs of treated and control mice. In addition, recovery by the homeopathic drugs, if any, of tissue damage inflicted because of chronic feeding of p-DAB and PB was also assessed by optical, scanning, and transmission electron microscopies of liver done at days 60 and 120. Both Carcinosin 200 and Chelidonium 200 when administered alone show considerable ameliorative effect against p-DAB-induced hepatocarcinogenesis in mice; but the conjoint feeding of these two drugs appears to have had a slightly greater protective effect. These homeopathic remedies have the potential to be used as complementary and alternative medicine in liver cancer therapy, particularly as supporting palliative measures.Keywords
This publication has 17 references indexed in Scilit:
- Assessment of the genotoxic and cytotoxic potential of an anti-epileptic drug, phenobarbital, in mice: a time course studyMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2004
- The current position of complementary/alternative medicine in cancerEuropean Journal of Cancer, 2003
- Towards understanding molecular mechanisms of action of homeopathic drugs: An overviewMolecular and Cellular Biochemistry, 2003
- Attitudes and Use of Complementary Medicine in Men with Prostate CancerJournal of Urology, 2002
- Oxidative DNA Damage Induced by an N‐Hydroxy Metabolite of Carcinogenic 4‐DimethylaminoazobenzeneJapanese Journal of Cancer Research, 2001
- Potentized homoeopathic drugs act through regulation of gene-expression: a hypothesis to explain their mechanism and pathways of action in vitroComplementary Therapies in Medicine, 1997
- Enhancement of the stress response by minute amounts of cadmium in sensitized Reuber H35 hepatoma cellsToxicology, 1997
- Benzophenanthridine Alkaloids ofChelidonium majus; II. Potent Inhibitory Action Against the Growth of Human KeratinocytesPlanta Medica, 1996
- Benzophenanthridine Alkaloids ofChelidonium majus; I. Inhibition of 5- and 12-Lipoxygenase by a Non-Redox MechanismPlanta Medica, 1996
- Critical Review and Meta-Analysis of Serial Agitated Dilutions in Experimental ToxicologyHuman & Experimental Toxicology, 1994